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Abstract
Exposure to diesel exhaust (DE) is known to exacerbate allergic inflammation, including virus-induced eosinophil
activation in laboratory animals. We have previously shown that in human volunteers with allergic rhinitis a short-
term exposure to DE prior to infection with the live attenuated influenza virus (LAIV) increases markers of allergic
inflammation in the nasal mucosa. Specifically, levels of eosinophilic cationic protein (ECP) were significantly
enhanced in individuals exposed to DE prior to inoculation with LAIV and this effect was maintained for at least
seven days. However, this previous study was limited in its scope of nasal immune endpoints and did not explore
potential mechanisms mediating the prolonged exacerbation of allergic inflammation caused by exposure to DE
prior to inoculation with LAIV. In this follow-up study, the methods were modified to expand experimental endpoints
and explore the potential role of NK cells. The data presented here suggest DE prolongs viral-induced eosinophil
activation, which was accompanied by decreased markers of NK cell recruitment and activation. Separate in vitro
studies showed that exposure to DE particles decreases the ability of NK cells to kill eosinophils. Taken together, these
follow-up studies suggest that DE-induced exacerbation of allergic inflammation in the context of viral infections may
be mediated by decreased activity of NK cells and their ability to clear eosinophils.
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Background
Studies in experimental animal models and controlled
human exposures suggest that exposure to diesel ex-
haust (DE) or DE particles may act to heighten allergic
respiratory inflammation and immune responses, espe-
cially in the context of viral infections [1, 2]. We have
previously demonstrated that in mice sensitized to ov-
albumin, exposure to DE particles prior to infection with
influenza virus significantly enhances allergic inflamma-
tion, as marked by influx of eosinophils [3]. Similarly,
published data from our group found that short-term
exposure of human volunteers to DE (100 μg/m3 for 2 h)
significantly increases live attenuated influenza virus
(LAIV)-induced eosinophilic cationic protein (ECP) levels
and virus quantity in nasal secretions of allergic rhinitic
adult volunteers [4]. Analysis of ECP levels in nasal lavage
is a marker of eosinophil degranulation and has been used
as an indicator of nasal eosinophilia in previous clinical
studies [5–7]. Interestingly, enhanced ECP levels were
seen for many days after DE exposure and infection with
LAIV, suggesting that the increased markers of eosinophil
activation persisted after the virus had been cleared. Thus,
in both mouse and human in vivo models, exposure to DE
prior to infection with virus significantly increases eosino-
philia and markers of eosinophilic inflammation. However,
potential mechanisms mediating the enhanced and per-
sistent activation of eosinophils in the airways after expos-
ure to DE is not clear.
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In recent years, understanding of resolution of allergic
inflammation and the role of natural killer (NK) cells in
these responses has increased greatly. In addition to
clearing tumor and virus-infected cells, multiple recent
studies have implicated NK cells in the resolution of al-
lergic inflammation, as reviewed by Barnig and Levy [8].
Most notably, mice depleted of NK cells were found to
have increased viral-induced Th2 responses in response
to RSV challenge [9]. Additionally, NK cells have been
shown to aggregate in the respiratory tissue draining
lymph nodes in a mouse model of allergic inflammation;
depletion of these cells or interference with their recruit-
ment delayed resolution [10]. In human experiments,
co-culture of NK cells with autologous eosinophils pro-
moted apoptosis of eosinophils [11, 12], supporting a
role for NK cells in resolving eosinophilia. Previous stud-
ies from our group have demonstrated a marked de-
crease in nasal NK cell cytokine production, cytotoxic
granule production, and cell-mediated cytotoxicity when
they are exposed to DE particles in vitro [13]. We there-
fore hypothesized that elevated and prolonged nasal ECP
levels as a marker for eosinophilia in allergic subjects ex-
posed to DE prior to inoculation with LAIV may be
caused by DE-induced suppression of NK cell function.
The purpose of this study was to connect persistent ECP
levels in DE-exposed allergic rhinitics with impaired NK
cell function in an in vivo exposure model.
Methods
In vivo exposure
A total of 22 otherwise healthy allergic rhinitics (n = 11
per treatment group) were recruited and completed the
study protocol depicted in Fig. 1a. Subjects were skin
tested for sensitivity to a panel of common household
and environmental allergens. Age, gender, and BMI did
not significantly differ between the treatment groups
(Table 1). Subjects were randomized to be exposed to ei-
ther clean air or 110 μg/m3 (total particles; see Table 2)
of DE for 2 h produced by a Cummins diesel generator
running at 25 % load, with an organic carbon (OC):ele-
mental carbon (EC) ratio of 0.4 for diesel particles. The
detailed methods for determining OC:EC in this system
have been reported elsewhere [14] and levels of gas-
phase pollutants and particle characterizations are sum-
marized in Tables 2 and 3 and Fig. 1b. Immediately fol-
lowing exposure to air or DE, subjects were given a
standard dose of LAIV in both nostrils to simulate an in-
fluenza virus infection. Nasal lavage samples were col-
lected prior to exposure and at days 1, 2, and 7–10 post
exposure and LAIV [3]. A schematic of the experimental
design is summarized in Fig. 1a. Cell free nasal lavage
fluid (NLF) samples were analyzed for mediators related
to eosinophil and NK cell recruitment and activation, as
well as pro-inflammatory cytokines and chemokines.
Immune cells isolated from the lavage were subjected to
flow cytometric staining and characterization. The study
was approved by the UNC Biomedical Institutional Re-
view Board and by the U.S. Environmental Protection
Agency.
Collection and processing of nasal lavage fluid
Sterile saline (0.9 % NaCl w/v) was aerosolized and in-
haled 5 times into one nostril and expelled into a sample
cup while occluding the opposite nostril. This was re-
peated a total of 8 times for each side. The lavage was
pipetted through a 40 μm cell strainer to remove large
debris, squamous epithelial cells, and mucous, and the
filtered fraction centrifuged to obtain a cell pellet and
cell-free nasal lavage fluid fraction. The contents of the
cell strainer were treated with a 20× dilution of Sputoly-
sin® reagent (EMD Millipore), then pipetted through a
second cell strainer, and the resulting cell pellet com-
bined with the initial cell pellet for downstream analysis.
Protein expression in cell-free nasal lavage fluid
Cell-free nasal lavage fluid was assayed for chemokine
and pro-inflammatory cytokine expression via Meso-
Scale Discovery® multi-spot assay system (Human
Fig. 1 a Schematic of treatment protocol; b Representative Particle Size
characteristics measured by Scanning Mobility Particle Sizer (SMPS™)
Table 1 Demographic information for enrolled subjects
Demographic Air (n = 11) DE (n = 11) p-value
Age (yr)a 27.5 ± 8.7 25.6 ± 4.7 0.52
BMIa 27.2 ± 5.8 25 ± 5.4 0.37
Male/femaleb 8/3 5/6 0.38
at-test, bFisher’s exact test
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Chemokine Panel 1 and Pro-Inflammatory Panel 1, re-
spectively). Eosinophilic cationic protein, perforin, and
granzyme B levels were measured via commercially
available sandwich ELISA.
Surface marker phenotyping of nasal lavage leukocytes
The cellular fraction of the nasal lavage fluid was sub-
jected to an F(c) block, and incubated with antibodies
against human CXCR3-PE-Cy5.5, CD56-PE, CD16-
FITC, CD3-APC, and CD45-APC-Cy7. Cells were
washed, fixed, and acquired on a BD™ LSR II flow cyt-
ometer. Compensation was performed with BD™ Anti-
Mouse Ig CompBeads per manufacturer instructions,
and IgG1 isotype controls were performed using autolo-
gous peripheral blood mononuclear cells from each
subject.
In vitro cytotoxicity challenge
Peripheral blood was collected from 7 healthy human
subjects. NK cells enriched via density centrifugation to
isolate peripheral blood mononuclear cells, and NK cells
isolated from these using the Dynabeads® Untouched™
Human NK Cell negative selection kit (ThermoFisher Sci-
entific). NK cells were incubated with vehicle (buffered sa-
line) or DE particles obtained from exposure chamber
filters, sonicated into an HBSS suspension, at a concentra-
tion of 10 μg/mL in RPMI-1640 media supplemented with
10 % fetal bovine serum overnight. Following treatment,
NK cells were co-incubated with a CFSE-labeled eosino-
phil cell line (EOL-1) at a 3:1 NK to target cell ratio for
four hours and both cell types stained with Live/Dead®
Fixable Dead Cell Stain (ThermoFisher Scientific). Cells
were acquired as described above.
Statistics
Measurements for each subject were normalized to their
individual baseline and expressed as fold change relative
to baseline. Baseline values did not significantly differ be-
tween treatment groups (Table 4). Differences amongst
exposure groups and between treatment days and baseline
were compared using Mann-Whitney non-parametric t-
tests via GraphPad Prism v.6. P < 0.05 was considered
significant.
Results
ECP levels did not differ between treatment groups at
baseline (day 0) (Table 4), but subjects exposed to DE
prior to inoculation with LAIV demonstrated a signifi-
cant increase in ECP in the NLF from baseline at days 1,
2, and 7–10, which was not apparent in subjects exposed
to air prior to inoculation with LAIV (Fig. 2a). Persist-
ently elevated ECP suggests that eosinophils in these
subjects remained within or near the nasal mucosa
throughout the course of the study. There was a very
small but significant increase in Eotaxin-1 in all days in DE
exposed subjects and day 2 in air-exposed subjects (Fig. 2b),
which may result in increased eosinophil recruitment. NLF
protein analysis revealed no difference between air- and
DE-exposed groups for changes in the cytokines IL-2, IL-4,
IL-5, IL-10, IL-13, IFN-γ, or TNF-α, or the chemokines
eotaxin-3, MCP-1, MCP-4, MDC, MIP-1β or TARC, at any
of the time points (data not shown), which is consistent
with the type of diesel utilized in this study and the
overall dose of DEP [4, 15–18]. DE-exposed subjects
demonstrated a significant reduction in the NK-
recruiting and activating cytokine IP-10 at day 1 post
exposure in NLF (Fig. 2c), though expression of the
IP-10 receptor, CXCR3, was not significantly reduced
amongst CD3−CD45+CD16+CD56+ NK cells (Fig. 2d).
These differential expression patterns were not due
to changes in NK cell number between treatment
groups (Table 5).
NLF samples from both treatment groups were ana-
lyzed for mediators released as part of NK cell cytotoxic
granules. There was a reduction in granzyme B protein
at day 7–10 in the DE exposed group (Fig. 3a) and a
trend towards decreased perforin expression at the same
time point (Fig. 3b). To further confirm that DE expos-
ure impairs NK cell cytotoxic function, NK cells were
isolated from peripheral blood of healthy donors and in-
cubated with either vehicle (buffered saline) or 10 μg/
mL of DE particles overnight before co-culture with an
eosinophil cell line, EOL-1, at a 3:1 NK to target cell ra-
tio. Similar to our previous studies [13], incubation of
the NK cells with the EOL-1 cell line as target cells in-
duced significant target cell killing, as determined by a
Table 2 DE Particle characteristics
TEOM® (μg/m3 ± Std. Dev.)
(min-max)
110.53 ± 0.62 μg/m3 (109.27–111.74)
Particle Conc. (⋕/cc ± Std. Dev.)
(min-max)
236,297 ± 35,780 (197,181–297,240)
Number Mean Diameter
(μm± Std. Dev.) (min-max)
0.0375 ± 0016 μm (0.0350–0.0400)
Table 3 Exposure concentrations for Air and DE-exposure groups. Data are the ranges from direct measurements of DE components
monitored continuously for all subjects
Group PM NO NO2 CO SO2
Air N/A 0.00–0.01 ppm 0.00 ppm 0.00–0.07 ppm 0.001–0.004 ppm
DE 109.3–111.7 μg/m3 0.037–0.47 ppm 0.347–0.476 ppm 0.75–1.03 ppm 0.002–0.007 ppm
PM particulate matter concentration exposure concentration, NO nitric oxide, NO2 nitrous oxide, CO carbon monoxide, SO2 sulfur dioxide
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Table 4 Raw values (+/− standard deviation) for proteins measured at each time point
Analyte A0 D0 p-value
Air vs.
Diesel
A1 p-value
fold
Change
vs. day 0
D1 p-value
fold
Change
vs. day 0
p-value
day 1 Δ
Air vs. Δ
Diesel
A2 p-value
Fold
Change
vs. day
D2 p-value
Fold
Change
vs. day
p-value
day 1 Δ
Air vs. Δ
Diesel
A7-10 p-value
Fold
Change
vs. day
D7-10 p-value
Fold
Change
vs. day
p-value
day 1 Δ
Air vs. Δ
Diesel
ECP
(pg/mL)
160.80 ±
168.02
88.60 ±
136.33
0.26 92.78 ±
111.3
0.28 112.1 ±
97.54
0.10 0.04 134.0 ±
177.0
0.55 98.77 ±
88.44
0.02 0.02 158.7 ±
226.9
0.56 87.99 ±
93.66
0.24 0.20
Eotaxin-1
(pg/mL)
457.94 ±
456.0
386.76 ±
190.12
0.73 498.47 ±
413.36
0.16 541.76 ±
180.13
0.01 0.64 541.29 ±
302.67
0.01 573.27 ±
164.43
0.01 0.20 611.63 ±
378.14
0.09 734.22 ±
418.35
0.06 0.78
IP-10
(pg/mL)
12923.64 ±
26721.96
9991.60 ±
18496.68
0.98 21627 ±
50661
0.11 6829 ±
13175
0.02 0.007 62228 ±
168311
0.003 18059 ±
32152
0.16 0.08 37629 ±
100776
0.08 27868 ±
64717
0.05 0.81
CXCR3
(MFI)
10050.0 ±
368.76
13521.22 ±
6214.61
0.40 8693.36 ±
4076.98
0.69 8551.67 ±
630921
0.44 0.15 8921.27 ±
2520.99
0.81 8604.67 ±
3702.20
0.16 0.21 9858.60 ±
2904.61
0.47 9534.75 ±
5619.12
0.13 0.53
Granzyme
B (pg/mL)
59.99 ±
105.89
21.58 ±
15.63
0.21 38.26 ±
33.15
0.82 34.08 ±
30.00
0.05 0.098 50.37 ±
55.84
0.13 29.75 ±
32.93
0.17 0.92 38.19 ±
46.88
0.92 166.47 ±
393.99
0.009 0.098
Perforin
(pg/mL)
161.29 ±
413.53
51.61 ±
33.61
0.39 126.65 ±
276.71
0.70 83.97 ±
97.26
0.12 0.22 123.32 ±
257.77
0.56 55.80 ±
36.13
0.21 0.47 211.79 ±
391.73
0.85 218.74 ±
429.65
0.10 0.22
MFI mean fluorescence intensity. P values based on fold change over each individual’s baseline (D0) value. P value between treatment groups compares protein expression relative to baseline, air exposure vs. diesel
exposure. P-values generated via un-paired, non-parametric Mann-Whitney t-test
significant differences are in bold
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fluorescent viability stain and flow cytometry, and this
killing was blunted by exposure to DE particles (Fig. 3c).
Loss of NK cell cytotoxic function was not due to DE
treatment-induced apoptosis of NK cells (Fig. 3d). These
data suggest that DE-induced suppression of NK cell
function is associated with decreased ability to kill eosin-
ophils, thus prolonging ECP persistence in the nasal
lavage.
Discussion
The data presented in this short report confirm that ex-
posure to DE prior to inoculation with LAIV causes a
significant immediate increase in ECP levels, which
remained elevated as compared to baseline at least 7–10
days post-exposure and infection. While the initial in-
crease in ECP levels may be caused by increased viral in-
fection, our data also suggest that DE-induced reduction
of NK cell killing function may be a mechanism by
which DE reduces the ability to clear eosinophils and
thus prolongs eosinophilic inflammation in allergic and
asthmatic individuals. While previous rodent and human
in vivo exposure studies have demonstrated the in-
creased and persistent presence of eosinophils in the re-
spiratory mucosa after exposure to DE and infection
with influenza virus [2–4, 19], mechanisms mediating
these responses were not clear. Data summarized in this
follow-up study suggest that while the initial recruitment
of eosinophils into the airways may be mediated by the
effect DE has on enhancing viral infections [16, 18], the
prolonged eosinophil activation seen in allergic rhinitics
exposed to DE prior to inoculation with LAIV may be
mediated by reducing activation of NK cells and their
ability to kill eosinophils, which adds to the existing evi-
dence implicating NK cells as active players in the reso-
lution of eosinophilia [8].
The cellular mechanisms by which DE particles might
affect NK cell function or affect NK cell-dependent
clearance of eosinophils are not known. We and others
have previously shown inhibitory effects of DE particles
on lymphocyte cytotoxic function [13, 20]. NK cell acti-
vation depends on the expression of activating receptors,
such as CD16, NKG2D, and NKp46. NK cell mediated
apoptosis of neutrophils has been shown to be contact
dependent and mediated by NKp46 and Fas [21], while
NK cell-mediated killing of autologous eosinophils was
mediated by pro-resolvin receptors [12]. We have previ-
ously demonstrated that NK cells exposed to DE parti-
cles prior to stimulation with the viral mimetic poly I:C
Fig. 2 a protein expression of eosinophil cationic protein (ECP), b eotaxin-1, and c IP-10 in nasal lavage fluid, and d CXCR3 on NK cells isolated from nasal
lavage. *p < 0.05 vs. baseline (day 0 or screen day), # p < 0.05 vs. air exposure, Mann-Whitney test. MFI = mean fluorescence intensity; A = Air
exposure, D = Diesel exhaust exposure, number indicates days post-LAIV treatment
Table 5 Phenotyping of cells in nasal lavage (+/− standard deviation) via flow cytometry
Endpoint A0 D0 A1 D1 A2 D2 A7-10 D7-10
% Neutrophils
(CD45+/CD56-/CD16+
54.36 ± 26.02 53.06 ± 27.49 60.49 ± 15.63 59.79 ± 19.25 58.42 ± 19.12 67.66 ± 11.41 54.62 ± 21.42 64.85 ± 17.18
% NK Cells
(CD45+/CD56+/CD3-)
21.77 ± 12.48 24.0 ± 14.07 26 ± 7.69 23.43 ± 8.25 24.02 ± 6.84 22.66 ± 6.75 32.63 ± 18.38 23.36 ± 5.76
% CXCR3+ NK Cells 92.29 ± 19.47 98.99 ± 1.09 99.06 ± 0.99 94.56 ± 8.72 99.08 ± 0.82 92.94 ± 11.32 97.94 ± 3.68 88.5 ± 18.99
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have reduced expression of CD16 [13], a marker of over-
all NK cell cytotoxic activity. Thus, exposure to DE in
the context of viral infection may reduce the expression
of activating or pro-resolvin receptors on NK cells.
There is also evidence to support a DE-induced imbal-
ance of pro- and anti-inflammatory lipid mediators,
which may preclude NK-cell granulocyte apoptosis [22].
We cannot exclude the possibility that there may be
other sources of granzyme B and perforin, such as CD8+
T cells, however, based on our previous characterization
of the cellular content of human nasal lavage [23] and
the phenotyping we presented in Table 5, it is most
likely that these proteins are derived from NK cell de-
granulation. One potential limitation of the data pre-
sented here is the inability to directly test the effects of
DE exposure on nasal NK cells to induce eosinophil
apoptosis in our human volunteers, since in vitro NK
cell cytotoxic activity towards EOL-1 cells may involve
other and/or additional mechanisms than those involved
in killing eosinophils in the nasal mucosa in vivo. As a
surrogate for nasal NK cell activity we assessed nasal lav-
age fluid levels of granzyme B, which was reduced in
subjects exposed to DE. However, the much more lim-
ited time course of our ex vivo analysis on the effects of
DE particles on NK cell cytotoxic function against eosin-
ophils as compared to the reduced levels of granzyme B
observed in the nasal lavage of DE-exposed subjects pro-
hibits us to establish a direct cause-and-effect
relationship in humans exposed to DE prior to inocula-
tion with LAIV.
Despite the limitations of our small clinical cohort,
and the caveats inherent in dealing with primary human
samples (i.e., limitations in selecting time points, sub-
stantial dilution of protein analytes in nasal lavage, in-
ability to measure eosinophil cell numbers in nasal
lavage directly, etc.), we feel these data add significantly
to our previous diesel exposure studies. The effects of
DE on eosinophil-mediated inflammation have been de-
scribed in guinea pigs and mice exposed to high levels of
DE before [24–28]. However, our previous studies in
mice demonstrated that in allergic airway disease, expos-
ure to lower levels of DE particles alone does not en-
hance markers of eosinophilia, while DE prior to
infection with influenza does [3, 16, 18]. In addition, re-
cently published data exposing allergic asthmatics to
DE/Air alone or with allergen challenge demonstrates
that DE alone at levels similar to ours does not enhance
markers of eosinophilia in allergic subjects [1, 19, 29],
which is in agreement with our previous mouse study
[3], and reinforces the concept that DE at these exposure
levels may have little impact on its own, but a significant
impact on a second stimulus. While we cannot exclude
any possible direct effect of DE on ECP levels or eosino-
philia in the nasal mucosa, the primary goal of this study
design was to compare the effects of relevant levels of
DE followed by viral infection, to air followed by viral
Fig. 3 Protein expression of a granzyme B and b perforin in nasal lavage fluid. *p< 0.05 vs. air control, # p< 0.05 vs. baseline (day 0), Mann-Whitney test.
c NK cell cytotoxic activity against EOL-1 target cells as determined via flow cytometry, n= 7 individual subjects. d % Dead NK cells after 24 h culture with
10 μg/mL diesel particles. * p< 0.05, Mann-Whitney test. A = Air exposure, D =Diesel exhaust exposure, number indicates days post-LAIV treatment
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infection in allergic rhinitics. More specifically, our aim
in this study was to expand upon our earlier observation
that ECP levels indeed remained elevated longer than
enhanced markers of viral replication in subjects ex-
posed to DE prior to inoculation with LAIV [4]. How-
ever, similar to our previous study a DE-alone arm was
not included in the clinical study design, which pre-
cludes us from excluding the possibility that DE expos-
ure may have a direct effect on ECP levels in subjects
with allergic rhinitis.
Since experimental models suggest that DE organic
carbon, specifically polycyclic aromatic hydrocarbon
(PAH), may be an important variable affecting this
process [15], it is important to note that we carried out
the current protocol using a different diesel engine as
compared to the one used in our previous study [4],
which had a higher OC:EC ratio. The effects of the DE
used in this study on ECP and NK cell are consistent
with our previous work, however some differences were
noted as well. We did not previously note a significant
DE effect on IP-10, and unlike our prior study, here we
did not observe a DE-associated increase IFNγ levels in
the context of LAIV [3]. However, due to the limitations
of the experimental conditions of the clinical study, we
cannot rule out any DE-induced changes to IFNγ or any
of the other measured endpoints prior to the first time
point, which was approximately 24 h after the DE expos-
ure and inoculation with LAIV. Exposure levels to the
non-particulate National Ambient Air Quality Standards
(NAAQS) “criteria” pollutants CO, NO2, and SO2
(Table 3) tended to be somewhat lower in the current
study than in the previous study, which used emissions
from an idling truck system [4]. It is possible that one or
more of these factors could affect the outcomes for some
of the endpoints. However, unlike the particulates, levels
of these pollutants in both studies were orders of magni-
tude lower than the current thresholds for prevention of
health effects in sensitive populations or previously re-
ported to have significant effects on respiratory out-
comes in allergic airways [30]. It is thus likely that the
effects observed were due to DE particulates.
Conclusion
While our human exposure system limits the ability to test
the interaction between respiratory mucosal NK cells and
eosinophils in depth mechanistically, the effects of DE par-
ticles on the ability of NK cells to kill eosinophils, even at
a comparatively low dose, provides a powerful proof of
concept building on ideas presented in the literature. Our
data also introduces an important new clinical paradigm
involving the effects of inhaled ambient air pollutants on
NK cells and the reduced ability to clear eosinophils, thus
exacerbating and prolonging allergic inflammation. These
results are also of potential importance for public health,
since exposure to particulate and traffic-related pollution,
asthma, and viral infections frequently overlap, particu-
larly in urban areas. Continuing to uncover mechanisms
for how these factors interact will be critical to addressing
the effects of environmental pollutants on human respira-
tory health.
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